Nucleobindin-2 Mediates Transforming Growth Factor-β1–Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1–High Uterine Carcinosarcoma-Reference-Cited by-同舟云学术

Nucleobindin-2 Mediates Transforming Growth Factor-β1–Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1–High Uterine Carcinosarcoma

Published:2023-08 Issue:8 Volume:193 Page:1116-1128
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Kobayashi Yui,Yokoi Ako,Hashimura Miki,Oguri Yasuko,Konno Ryo,Matsumoto Toshihide,Tochimoto Masataka,Nakagawa Mayu,Ishibashi Yu,Ito Takashi,Ohhigata Kensuke,Harada Yohei,Fukagawa Naomi,Kodera Yoshio,Saegusa Makoto

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference47 articles.

1. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?;McCluggage;J Clin Pathol,2002

2. Uterine carcinosarcomas (malignant mixed mullerian tumors) are metaplastic carcinomas;McCluggage;Int J Gynecol Cancer,2002

3. The epidemiology of sarcomas of the uterus;Harlow;J Natl Cancer Inst,1986

4. Uterine sarcomas: a review;D'Angelo;Gynecol Oncol,2010

5. Monoclonal origins of malignant mixed tumors (carcinosarcoma): evidence for a divergent histogenesis;Thompson;Am J Surg Pathol,1996

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleobindin 2 inhibits senescence in gastric carcinoma;Scientific Reports;2024-05-17

2. Fabricating Ultra-Narrow Precision Slit Structures with Periodically Reducing Current Over-Growth Electroforming;Micromachines;2023-12-29

3. Cytoplasmic Shotgun Proteomic Points to Key Proteins and Pathways in Temozolomide-Resistant Glioblastoma Multiforme;Journal of Proteome Research;2023-12-26

4. A Complex Interplay between Notch Effectors and β-Catenin Signaling in Morular Differentiation of Endometrial Carcinoma Cells;The American Journal of Pathology;2023-12

5. Nucleobindin 2 inhibits senescence in gastric carcinoma;2023-11-28